USP resolutions emphasize information databases for standards; address off-label use data dissemination.
USP RESOLUTIONS HIGHLIGHT INFORMATION TOOLS to disseminate standards and enhance disease management. On March 12, during its quinquennial meeting in Washington, D.C., the United States Pharmacopeia passed 13 proposed resolutions. Resolution four calls for the expansion of the scope of the USP Di-AMA DE Database "to facilitate rational therapeutic decision making and appropriate drug administration and use." The USP believes this action will enhance disease management and patient care.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth